🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#CART ID practices effort — kudos to Zainab Shahid MD, FACP, FIDSA 🇺🇸🇵🇰 for leading this and rescuing this effort from ASTCT , and to all contributors for the critical contributions Martina Pennisi Joshua Hill, MD Swetha Kambhampati Lekha Mikkilineni and others

Bispecific antibody therapy is a novel immunotherapy 💊 for hematologic malignancies, but opportunistic infections 🦠remain a serious concern. Here we report the first case of disseminated MAC infection in a patient on BsAb tx Ben Teh Eddie Cliff academic.oup.com/ofid/advance-a…

JOB POSTING: CIBMTR is seeking a part time (0.1 FTE) Scientific Director to lead our Infection and Immune Reconstitution Working Committee. Learn more about this important position, here: cibmtr.org/Files/Careers1… NMDP

Hypogammaglobulinemia, infections/severe infections, and antimicrobial use were decreased in patients with CLL or NHL treated with IgRT. ow.ly/tCYK50T7N6E #lymphoidneoplasia #healthservicesandoutcomes

rdcu.be/dTNWp HHV-6 viremia associated with overall and non-relapse mortality after HCT in a meta-analysis. Is this causal? We need safer prophylactic therapies to test whether we can do for HHV-6 what letermovir did for CMV and improving overall survival. @astct

I had a great meeting with staff members from @FredHutch, where we discussed their lifesaving work and the need to increase resources and expand access to clinical trials for those who are immunocompromised.

Thanks to Rep. Kim Schrier, M.D. for meeting with our physician researchers to discuss the development of immunologic approaches to prevent and treat infections in #immunocompromised individuals. Joshua Hill, MD @PergamIC

.Zainab Shahid MD, FACP, FIDSA 🇺🇸🇵🇰 et al. Congrats. Important paper

【Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections】Curr Opin Infect Dis, Oct 5 2024 👉Congrats, Erika Erika Kampouri Fred Hutch Cancer Center Université de Lausanne🎉 👉Comprehensive review on the epidemiology of viral infections and critical approaches to

A growing number of American adults have weakened immune systems, which can leave them vulnerable to severe illnesses. Fred Hutch's Joshua Hill, MD discusses the implications of being immunocompromised with the The New York Times. 👉 nyti.ms/3BCAbS1

"We're the National Institutes of Health, not the National Institutes of Not Dying," said Dr. Keith Jerome of Fred Hutch, who explained how community advocacy has elevated the importance of #HSV #cure research at the NIH and other federal funding sources. bit.ly/3U42C1y

Interested in learning about the cutting edge in management of infections in HCT, CAR-T, and SOT recipients? Pls mark your calendars for May 11-14, 2025, for the 5th symposium on infections in immunocompromised individuals. Travel stipends available! bit.ly/4hgyLwS

fredhutch.org/content/www/en… via Fred Hutch Cancer Center With increasing infectious disease threats plus a growing population of people with weakened immune systems, we think the time is right to establish a national network dedicated to trials at this intersection.

Want to learn the current state of the art for prevention of RVI in immunocompromised patients? Join us for the next ESCMID ESGICH/ESGREV webinar on the prevention of RVI. Chaired by Elisa Cordero, Barbara Rath Talks by Lior Nesher Michael Ison, MD MS @Joshua Hill, MD

Join us in accelerating groundbreaking discoveries in #infectiousdiseases and #immunology! Fred Hutch is seeking a scientific leader for the Bezos Family Distinguished Scholar in Viruses and Vaccines faculty position. Learn more and apply: bit.ly/488PkH4

Initiating Long Covid RECOVERy | Science Translational Medicine science.org/doi/10.1126/sc… we have a lot of work to do here. Let’s not lose the momentum NIAID News NIH NHLBI NINDS